Strategy ( (MSTR)) has issued an announcement. On December 29, 2025, Strategy Inc. reported that, between December 22 and December 28, 2025, it sold 663,450 shares of its MSTR Class A common stock ...
Strategy Inc (NASDAQ:MSTR) reported Monday that during the week of December 15 to December 21, it did not sell any shares under its at-the-market (ATM) offering program for its listed securities. The ...
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...
Clinical strategy - The FLAMINGO-01 clinical strategy continues to evolve with various options to further reduce risk and increase the chances of marketing approval supported by the current financing ...
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...
Hosted on MSN
Strategy raises $747.8M in its latest MSTR ATM sale
Strategy achieved another significant weekly raise, but bought no new BTC. Instead, the company pushed up its cash reserves, securing the upcoming dividend payments. Strategy achieved another weekly ...
The Company recently attended a Noble Capital conference on December 3, 2025, where further details of the Company’s FLAMINGO-01 clinical strategy, financing strategy, and partnering strategy were ...
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. If you want to set aside your savings but are worried you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback